We retrospectively investigated the incidence of pancreatic ductal adenocarcinoma among patients with intraductal papillary mucinous neoplasms of the pancreas. Based on imaging in 195 such patients, we chose surgery as initial treatment for 54, and periodic evaluation over 6 to 192 months (mean, 52) for 141. In 6 of the 141 patients observed for intraductal papillary mucinous neoplasm (4.2%), p...

Pancreatic serous cystadenoma can be categorized into microcystic, honeycomb, oligocystic, and solid patterns based on imaging appearance. The presence of typical computed tomography (CT) features helps to differentiate serous cystadenomas from other cystic and solid pancreatic masses. Cases with atypical features present a diagnostic challenge as they can mimic malignant neoplasms. This articl...

Pancreatic cancer is one of the more difficult malignancies to treat, and there is a great need for less toxic, effective regimens. Immunotherapy has shown potential in the treatment of pancreatic cancer, and at ASCO 2013 there were several progressive advances in its clinical application. Abstracts #3067, #3049, #3007, #4040, #LBA4004, and #3090 will be discussed. New developments in the field...

Introduction Approximately 32,000 pancreatic neoplasms are diagnosed in the United States annually.1 Currently, carcinoma of the pancreas is the fourth most common cause of cancer death in both men and women in this country, after cancers of the lung, breast/ prostate, and colon. The most common presenting symptoms of pancreatic cancers are epigastric pain, obstructive jaundice, and weight loss...

Studies using genetically engineered mouse models indicate that RAF activation is sufficient to induce pancreatic intraepithelial neoplasms, suggesting that mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor-based combination approaches may have clinical use in patients with pancreatic ductal adenocarcinomas.

Pancreatic imaging is an essential tool in the early diagnosis and staging of pancreatic disease. This presentation reviews the most recent advances in pancreatic MR imaging. The specific modalities discussed include magnetic resonance imaging (MRI), and magnetic resonance cholangiopancreatography (MRCP), before and after secretin stimulation. Introduction With the advent of newer imaging techn...

The sensitivity of computed tomography (CT) in the diagnosis of pancreatic neoplasms and accurate tumor staging has significantly been improved by the use of thin-section multi-detector row CT techniques. Greater table speed, improved tube cooling, high resolution imaging and the possibility of isotropic voxels have led to optimal multiplanar reconstruction in any arbitrary plane and particular...